Abstract: A friction reducing treatment solution that includes water, from 100 to 500,000 ppm of total dissolved solids, and from 0.5 to 3 gallons per thousand gallons of a water-in-oil emulsion containing a water soluble polymer. The total dissolved solids include at least 10 weight percent of a multivalent cation. The water-in-oil emulsion includes an oil phase and an aqueous phase, where the oil phase is a continuous phase containing an inert hydrophobic liquid and the aqueous phase is present as dispersed distinct particles in the oil phase and contains water, the water soluble polymer, and surfactants and an inverting surfactant. The water soluble polymer is made up of 20 to 80 weight percent of a non-ionic monomer, 0.5 to 30 weight percent of a carboxylic acid containing monomer, and 5 to 70 weight percent of a cationic monomer and makes up from 10 to 35 weight percent of the water-in-oil emulsion.

Abstract: A aqueous solution that includes water, from 100,000 to 300,000 ppm of dissolved solids, from 0.5 to 3 gallons per thousand gallons of a water-in-oil emulsion, and an inverting surfactant. The water-in oil emulsion includes an oil phase and an aqueous phase where the oil phase is a continuous phase comprising an inert hydrophobic liquid and the aqueous phase is present as dispersed distinct particles in the oil phase. The aqueous phase contains water, a water soluble polymer, and surfactants. The water soluble polymer includes 30 to 50 weight percent of a non-ionic monomer, 5 to 15 weight percent of a sulfonic acid containing monomer, and 40 to 60 weight percent of a cationic monomer. The water soluble polymer makes up from 10 to 35 weight percent of the water-in-oil emulsion.

Abstract: Ampholyte polymeric compound that comprises at least one nonionic monomer, at least one sulfonic acid-containing monomer, and at least one cationic monomer may be useful in viscosifying treatment fluids for use in subterranean operations at a concentration of about 0.5 v/v % to about 30 v/v % of the treatment fluid. Such operations may involve introducing the treatment fluid into a wellbore penetrating a subterranean formation optionally at a pressure sufficient to create or extend at least one fracture in the subterranean formation.

Abstract: Ampholyte polymeric compounds that comprise at least one nonionic monomer, at least one sulfonic acid-containing monomer, and at least one cationic monomer may be useful as friction reducing agents in treatment fluids for use in subterranean operations at a concentration of about 0.001 v/v % to about 0.5 v/v % of the treatment fluid. Such operations may involve introducing the treatment fluid into a wellbore penetrating a subterranean formation optionally at a rate and/or a pressure sufficient to create or extend at least one fracture in the subterranean formation.

Abstract: A friction reducing treatment solution that includes water, from 100 to 500,000 ppm of total dissolved solids, and from 0.5 to 3 gallons per thousand gallons of a water-in-oil emulsion containing a water soluble polymer. The total dissolved solids include at least 10 weight percent of a multivalent cation. The water-in-oil emulsion includes an oil phase and an aqueous phase, where the oil phase is a continuous phase containing an inert hydrophobic liquid and the aqueous phase is present as dispersed distinct particles in the oil phase and contains water, the water soluble polymer, and surfactants and an inverting surfactant. The water soluble polymer is made up of 20 to 80 weight percent of a non-ionic monomer, 0.5 to 30 weight percent of a carboxylic acid containing monomer, and 5 to 70 weight percent of a cationic monomer and makes up from 10 to 35 weight percent of the water-in-oil emulsion.

Abstract: A aqueous solution that includes water, from 100,000 to 300,000 ppm of dissolved solids, from 0.5 to 3 gallons per thousand gallons of a water-in-oil emulsion, and an inverting surfactant. The water-in oil emulsion includes an oil phase and an aqueous phase where the oil phase is a continuous phase comprising an inert hydrophobic liquid and the aqueous phase is present as dispersed distinct particles in the oil phase. The aqueous phase contains water, a water soluble polymer, and surfactants. The water soluble polymer includes 30 to 50 weight percent of a non-ionic monomer, 5 to 15 weight percent of a sulfonic acid containing monomer, and 40 to 60 weight percent of a cationic monomer. The water soluble polymer makes up from 10 to 35 weight percent of the water-in-oil emulsion.

Abstract: Ampholyte polymeric compound that comprises at least one nonionic monomer, at least one sulfonic acid-containing monomer, and at least one cationic monomer may be useful in viscosifying treatment fluids for use in subterranean operations at a concentration of about 0.5 v/v % to about 30 v/v % of the treatment fluid. Such operations may involve introducing the treatment fluid into a wellbore penetrating a subterranean formation optionally at a pressure sufficient to create or extend at least one fracture in the subterranean formation.

Abstract: Ampholyte polymeric compounds that comprise at least one nonionic monomer, at least one sulfonic acid-containing monomer, and at least one cationic monomer may be useful as friction reducing agents in treatment fluids for use in subterranean operations at a concentration of about 0.001 v/v % to about 0.5 v/v % of the treatment fluid. Such operations may involve introducing the treatment fluid into a wellbore penetrating a subterranean formation optionally at a rate and/or a pressure sufficient to create or extend at least one fracture in the subterranean formation.